Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Compliance Director Ulatowski announces retirement

This article was originally published in The Silver Sheet

Executive Summary

CDRH Office of Compliance Director Tim Ulatowski will retire from FDA at the end of the year, the veteran agency staffer announced in an April 12 memo to staff. An opening for the director position was posted by FDA the same day. A smooth transition is important given CDRH's ambitious agenda for the coming years, Ulatowski said in his memo. "A break in permanent leadership for maybe a few months while all this is occurring would not be helpful," noted Ulatowski, who has been with FDA since 1974 and with the Office of Compliance since 2003. Once the new director is hired, Ulatowski will shift to a temporary advisory role until his retirement. "The fact that Tim has announced his retirement is a very gracious decision on his part, because he has allowed the center leadership to identify his successor and to put his successor in place in a timeframe in which Tim will still be available to mentor his successor," Steve Silverman, senior advisor to the center director, said May 5 at the MedCon medical device conference in Cincinnati

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT036476

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel